ROIVANT SCIENCES LTD. Cash Divested from Deconsolidation
ROIVANT SCIENCES LTD. (ROIV) reported Cash Divested from Deconsolidation of $4.42 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-20.
Financial Statements › Cash Flow › Cash
us-gaap:CashDivestedFromDeconsolidation · last filed 2026-05-20
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for the quarter ending 2026-03-31 was $4.42M, a 5870.27% increase year-over-year.
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for the quarter ending 2025-03-31 was $74.00K, a 90.80% decline year-over-year.
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for the quarter ending 2024-12-31 was $31.15M.
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for the quarter ending 2024-03-31 was $804.00K.
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for fiscal 2026 was $4.42M, a 85.85% decline from fiscal 2025.
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for fiscal 2025 was $31.22M, a 63.04% decline from fiscal 2024.
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for fiscal 2024 was $84.48M, a 1159.81% increase from fiscal 2023.
- ROIVANT SCIENCES LTD. cash divested from deconsolidation for fiscal 2023 was $6.71M, a 17094.87% increase from fiscal 2022.
| Period end | Cash Divested from Deconsolidation 3 month | Cash Divested from Deconsolidation 6 month | Cash Divested from Deconsolidation 9 month | Cash Divested from Deconsolidation 12 month |
|---|---|---|---|---|
| 2026-03-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $4.42M 10-K · filed 2026-05-20 | ||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-06 | |||
| 2025-03-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $31.22M derived: sum of 2 quarters · filed 2026-05-20 | $31.22M 10-K · filed 2026-05-20 | |
| 2024-12-31 | $31.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $31.15M 10-Q · filed 2026-02-06 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2024-03-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $804.00K derived: sum of 2 quarters · filed 2026-05-20 | $84.48M 10-K · filed 2026-05-20 | |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | $83.68M 10-Q · filed 2025-02-10 | ||
| 2023-09-30 | $83.68M 10-Q · filed 2024-11-12 | |||
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $3.09M derived: sum of 2 quarters · filed 2025-05-29 | $6.71M 10-K · filed 2025-05-29 | |
| 2022-12-31 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-13 | $6.71M 10-Q · filed 2024-02-13 | ||
| 2022-09-30 | $3.62M 10-Q · filed 2023-11-13 | |||
| 2022-03-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | $39.00K derived: sum of 2 quarters · filed 2023-06-28 | $39.00K derived: sum of 3 quarters · filed 2023-06-28 | $39.00K 10-K · filed 2023-06-28 |
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $0.00 10-Q · filed 2023-02-13 | |
| 2021-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-09-21 | |||
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | $0.00 derived: sum of 2 quarters · filed 2022-02-14 | $19.09M 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | $19.09M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $19.09M 10-Q · filed 2021-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |